Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac suppository for acute biliary pancreatitis
IRCT20181028041485N1Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of diclofenac in biliary pancreatitis (2 arms), sponsored by Kurdistan University of Medical Sciences. Primary endpoints: death, organ failure and 3 more. Started Mar 2017; status: completed.
02
Drugs
diclofenac
03
Conditions
biliary pancreatitis
Beyond the preview
Go deeper on IRCT20181028041485N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181028041485N1.